CC BY 4.0 · Surg J (N Y) 2016; 02(03): e70-e77
DOI: 10.1055/s-0036-1587691
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Systematic Review and Meta-Analysis of Preoperative Antisepsis with Combination Chlorhexidine and Povidone-Iodine

Benjamin M. Davies
1   Department of Neurosurgery, Greater Manchester Neuroscience Centre, Salford Royal Foundation Trust (SRFT), Salford, United Kingdom
,
Hiren C. Patel
1   Department of Neurosurgery, Greater Manchester Neuroscience Centre, Salford Royal Foundation Trust (SRFT), Salford, United Kingdom
› Author Affiliations
Further Information

Publication History

31 January 2016

12 July 2016

Publication Date:
10 August 2016 (online)

Abstract

Importance Effective preoperative antisepsis is recognized to prevent surgical site infection (SSI), although the definitive method is unclear. Many have compared chlorhexidine (CHG) with povidone-iodine (PVI), but there is emerging evidence for combination usage.

Objective To conduct a systematic review and meta-analysis to evaluate if combination skin preparation (1) reduces colonization at the operative site and (2) prevents SSI compared with single-agent use.

Data Sources A literature search of MEDLINE, Embase, and Cochrane Database of Clinical Trials was performed.

Study Selection Comparative, human trials considering the combination use of CHG and PVI, as preoperative antisepsis, to single-agent CHG or PVI use were included. Studies were excluded from meta-analysis if the use or absence of alcohol was inconsistent between study arms.

Data Extraction and Synthesis The study was performed using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.

Main Outcomes and Measures The primary outcome for meta-analysis was surgical site infection. The secondary outcome was colonization at the operative site.

Results Eighteen publications with a combination of CHG and PVI use were identified. Of these, 12/14 inferred promise for combination usage, including four trials eligible for meta-analysis. Only one trial reported SSI as its outcome. The remaining three considered bacterial colonization. Combination preparation had a pooled odds ratio for complete decolonization of 5.62 (95% confidence interval 3.2 to 9.7, p < 0.00001). There was no evidence of heterogeneity (Cochran's Q 2.1, 2 df, p = 0.35).

Conclusions and Relevance There is emerging, albeit low-quality, evidence in favor of combination CHG and PVI preoperative antisepsis. Further rigorous investigation is indicated.

 
  • References

  • 1 Langgartner J, Linde HJ, Lehn N, Reng M, Schölmerich J, Glück T. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters. Intensive Care Med 2004; 30 (06) 1081-1088
  • 2 Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20 (11) 725-730
  • 3 Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005; 60 (02) 93-103
  • 4 Thompson KM, Oldenburg WA, Deschamps C, Rupp WC, Smith CD. Chasing zero: the drive to eliminate surgical site infections. Ann Surg 2011; 254 (03) 430-436 , discussion 436–437
  • 5 Lister J. On a new method of treating compound fracture, abscess, etc. Lancet 1867; 89 (2274): 387-389
  • 6 Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 2013; 3 (03) CD003949
  • 7 Lee I, Agarwal RK, Lee BY, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol 2010; 31 (12) 1219-1229
  • 8 Noorani A, Rabey N, Walsh SR, Davies RJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone-iodine in clean-contaminated surgery. Br J Surg 2010; 97 (11) 1614-1620
  • 9 Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev 2014; (12) CD007892
  • 10 Hadiati DR, Hakimi M, Nurdiati DS, Ota E. Skin preparation for preventing infection following caesarean section. Cochrane Database Syst Rev 2014; (09) CD007462
  • 11 Anderson MJ, Horn ME, Lin Y-C, Parks PJ, Peterson ML. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. Am J Infect Control 2010; 38 (10) 826-831
  • 12 Oxford Centre for Evidence-Based Medicine. The Oxford Levels of Evidence 2. Available at: http://www.cebm.net/index.aspx?o=5653 . Accessed May 30, 2015
  • 13 Higgins JPT, Altman DG, Gøtzsche PC. , et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343 (02) d5928
  • 14 Schünemann HJ. [GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice]. Z Evid Fortbild Qual Gesundhwes 2009; 103 (06) 391-400
  • 15 Farber NJ, Chen AF, Bartsch SM, Feigel JL, Klatt BA. No infection reduction using chlorhexidine wipes in total joint arthroplasty. Clin Orthop Relat Res 2013; 471 (10) 3120-3125
  • 16 Ryan SL, Sen A, Staggers K, Luerssen TG, Jea A. ; Texas Children's Hospital Spine Study Group. A standardized protocol to reduce pediatric spine surgery infection: a quality improvement initiative. J Neurosurg Pediatr 2014; 14 (03) 259-265
  • 17 Mounsey JP, Griffith MJ, Tynan M. , et al. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J 1994; 72 (04) 339-343
  • 18 Haynes J, Leslie IJ, Speller DC. Are povidone-iodine compresses helpful in skin preparation for hip replacement surgery?. J Hosp Infect 1986; 7 (01) 96-98
  • 19 Roukis TS. Bacterial skin contamination before and after surgical preparation of the foot, ankle, and lower leg in patients with diabetes and intact skin versus patients with diabetes and ulceration: a prospective controlled therapeutic study. J Foot Ankle Surg 2010; 49 (04) 348-356
  • 20 Mashhadi SA, Loh CYY. Combination of chlorhexidine gluconate and PVP in surgical site antisepsis. J Wound Care 2012; 21 (03) 141
  • 21 Phillips M, Rosenberg A, Shopsin B. , et al. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol 2014; 35 (07) 826-832
  • 22 Burgher AH, Barnett CF, Obray JB, Mauck WD. Introduction of infection control measures to reduce infection associated with implantable pain therapy devices. Pain Pract 2007; 7 (03) 279-284
  • 23 Murillo MG, Alvarez P, Gomilla CM, Sanchez-Mariscal F, Pizones L, Zuniga L. Influence of perioperative protocol to reduce postoperative infection rates in spine surgery. Preliminary study. Eur Spine J 2013; 22 (Suppl. 05) 125-137
  • 24 Guzel A, Ozekinci T, Ozkan U, Celik Y, Ceviz A, Belen D. Evaluation of the skin flora after chlorhexidine and povidone-iodine preparation in neurosurgical practice. Surg Neurol 2009; 71 (02) 207-210
  • 25 May SR, Roberts DP, DeClement FA, Still Jr JM. Reduced bacteria on transplantable allograft skin after preparation with chlorhexidine gluconate, povidone-iodine, and isopropanol. J Burn Care Rehabil 1991; 12 (03) 224-228
  • 26 Ngai IM, Van Arsdale A, Govindappagari S. , et al. Skin preparation for prevention of surgical site infection after cesarean delivery: a randomized controlled trial. Obstet Gynecol 2015; 126 (06) 1251-1257
  • 27 Hort KR, DeOrio JK. Residual bacterial contamination after surgical preparation of the foot or ankle with or without alcohol. Foot Ankle Int 2002; 23 (10) 946-948
  • 28 Bekar A, Korfali E, Doğan S, Yilmazlar S, Başkan Z, Aksoy K. The effect of hair on infection after cranial surgery. Acta Neurochir (Wien) 2001; 143 (06) 533-536 , discussion 537
  • 29 Brooks RA, Hollinghurst D, Ribbans WJ, Severn M. Bacterial recolonization during foot surgery: a prospective randomized study of toe preparation techniques. Foot Ankle Int 2001; 22 (04) 347-350
  • 30 Sellers J, Newman JH. Disinfection of the umbilicus for abdominal surgery. Lancet 1971; 2 (7737): 1276-1278
  • 31 Ngai IM, Van Arsdale A, Govindappagari S. , et al. Skin preparation for prevention of surgical site infection after cesarean delivery: a randomized controlled trial. Obstet Gynecol 2015; 126 (06) 1251-1257
  • 32 Tschudin-Sutter S, Frei R, Egli-Gany D. , et al. No risk of surgical site infections from residual bacteria after disinfection with povidone-iodine-alcohol in 1014 cases: a prospective observational study. Ann Surg 2012; 255 (03) 565-569
  • 33 Cronquist AB, Jakob K, Lai L, Della Latta P, Larson EL. Relationship between skin microbial counts and surgical site infection after neurosurgery. Clin Infect Dis 2001; 33 (08) 1302-1308
  • 34 Davies BM, Patel HC. Letter to the editor: is a reduced duration of post-discharge surgical site infection surveillance really in our best interests?. Euro Surveill 2015; 20 (13) 42
  • 35 O'Shaughnessy M, O'Malley VP, Corbett G, Given HF. Optimum duration of surgical scrub-time. Br J Surg 1991; 78 (06) 685-686
  • 36 Morrison TN, Chen AF, Taneja M, Küçükdurmaz F, Rothman RH, Parvizi J. Single vs repeat surgical skin preparations for reducing surgical site infection after total joint arthroplasty: a prospective, randomized, double-blinded study. J Arthroplasty 2016; 31 (06) 1289-1294
  • 37 Davies BM, Patel HC. Does chlorhexidine and povidone-iodine preoperative antisepsis reduce surgical site infection in cranial neurosurgery?. Ann R Coll Surg Engl 2016; 98 (06) 405-408
  • 38 Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J 2008; 5 (03) 376-387